Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)

by Web team (HR) | Jun 24, 2024 | Publications

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Centre of the month: June 2024

by Web team (HR) | Jun 21, 2024 | Centre Recognition Award

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Centre of the month: February 2024

by Web team (HR) | Feb 21, 2024 | Centre Recognition Award

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Recruitment open to Spevigo (spesolimab)

by Web team (HR) | Feb 1, 2024 | News

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...

Recruitment re-open to Stelara, Humira, Amgevita, Hulio, Hyrimoz, Idacio, Yuflyma

by Web team (HR) | Jan 9, 2024 | News

BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...